Great Britain: Regulatory updates for medical devices

 

The United Kingdom as published a new Medical Devices (Amendment) Regulations 2026.

The measures will amend the Medical Devices Regulations 2002 (SI 2002 No 618, as amended) as applicable in Great Britain (GB). The amendments seek to update the pre-market requirements that manufacturers must meet before placing their devices on the GB market. This will help improve patient safety, enable swifter access to medical devices through streamlined, risk-based regulatory pathways and international reliance routes, and support innovation by modernising the Regulations, aligning them more closely with international best practice.

Key changes include:

1. Introduction of an international reliance scheme providing swifter routes to market for certain medical devices and in vitro diagnostic (IVD) devices.
2. Classification changes to general medical devices and IVD devices for more risk-proportionate regulation.
3. Enhanced safety and performance requirements for medical devices and IVD devices, supporting closer alignment with international regulatory approaches.
4. More comprehensive technical documentation requirements, including enhanced retention periods.
5. Strengthened requirements for medical devices to claim equivalence to an existing device.
6. Requirement for mandatory use of Unique Device Identifiers for medical devices and IVD devices along with implant cards for implantable medical devices, improving traceability, ability to manage adverse events, and transparency for patients.
7. Regulation of misleading or unsubstantiated claims about medical devices and IVD devices.
8. Broadening the circumstances in which electronic instructions for use can be adopted in place of physical instructions.

The Medical Devices Regulations 2002 have provided the regulatory framework for medical devices in Great Britain for over 20 years. Since their introduction, there have been significant developments in technology, clinical practice, and healthcare delivery, necessitating the modernisation of the framework to ensure continued suitability for current and future needs.

These reforms focus on improving patient safety and respond to recommendations in the Independent Medicines and Medical Devices Safety Review, which highlighted the need for improved safety measures for medical devices.

Alongside this, the planned reforms seek to increase alignment with international regulatory practices, supporting greater global harmonisation. This includes facilitating access to medical devices by minimising unnecessary duplication through the introduction of international reliance routes.

The proposed legislation is intended to stimulate innovation while upholding robust safety standards, ultimately serving the best interests of both patients and the UK healthcare sector.

To find out more about product compliance for medical devices, do not hesitate to contact the Product Compliance Institute directly.